Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abbott, adenosine, adulthood, affirmative, alcohol, alia, Amazon, Appeal, ASC, ATP, begun, Beudeker, bottle, Bounty, brick, Bruce, CAGR, calendar, calorie, caption, capture, Carlo, ChromaPharma, citizen, coenzyme, constant, COSO, counter, Covance, creative, Dec, deceptive, declaratory, denied, denying, devoted, Diagonal, distributor, diversifying, Doctrine, DSM, earnout, ecommerce, elevated, enrichment, essential, Euromonitor, evolve, Farr, flagship, flat, Friedman, German, hair, ham, Hong, hurt, injunctive, insulin, inter, internet, inventor, Ka, Kevin, Kong, Kornberg, Lanham, lattice, Laureate, lawfully, leave, Li, libel, licensee, licensor, likewise, Macau, Matthew, Mayo, mediation, mislabeled, Monte, mortar, neurology, Nobel, noncash, offshore, older, opposed, outlined, outweigh, passed, PCAOB, Pharmavite, physical, pioneering, prejudice, Preliminary, prescribed, privilege, Professor, prominent, propriety, PTAB, put, ratified, ratifying, regional, repatriated, repealing, reply, resubstitution, revalued, Roger, rose, scrutiny, SDNY, Shing, signature, Singapore, social, sought, Southern, spent, staffing, standalone, Stanford, statute, Ste, stead, strike, substitute, substitution, surgery, Tanzi, taxation, therewith, thing, thought, threshold, triphosphate, TRU, true, trustworthy, unallocated, uncover, underpricing, unjust, unweighted, urge, vehicle, virtue, young, younger, youth
Removed:
acid, adulterating, advanced, allocation, biological, biologically, blocking, BluScience, burgeoning, capitalization, cardiovascular, characterization, cognitive, collateral, Combining, commitment, compound, conditioned, conversion, copy, customary, dark, database, degeneration, demonstration, designation, differentiation, digital, diligence, discount, Dongmyung, draft, earn, efficiently, elaborate, equated, establishment, ethnobotanical, ethnopharmacological, exist, extra, Fast, fatty, fee, founder, gap, generation, Geographical, glucose, herbal, highlight, HVAC, inclusion, investigate, investigational, involving, ISO, JMC, Korea, layer, literature, manager, milk, mitochondrial, neuropathy, NeutriSci, nominal, noted, oxidation, parent, peripheral, pertaining, pigment, pipeline, potency, potent, preferred, presence, principally, proportion, purpose, rating, receptive, recruitment, referencing, repayable, resistance, revise, routine, satisfied, scenario, secondary, secure, Segmentation, settle, Silliker, structure, subscription, Tiger, trace, treat, uniformity, utilized, variability, week, writing
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Articles of Incorporation / Bylaws
- 10.66 Material Contracts
- 10.72 Material Contracts
- 21.1 Subsidiaries of the Registrant
- 23.1 Consents of Experts and Counsel
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated CDXC transcripts
CDXC similar filings
Filing view
External links
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350
(as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002)
In connection with this annual report of ChromaDex Corporation (the “Company”) on Form 10−K for the year ending December 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Frank L. Jaksch Jr., Chief Executive Officer of the Company, and Kevin Farr, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes−Oxley Act of 2002, that, to our knowledge:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: March 15, 2018
/s/ FRANK L. JAKSCH JR.
Frank L. Jaksch Jr.
Chief Executive Officer
/s/ KEVIN FARR
Kevin Farr
Chief Financial Officer
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of ChromaDex Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.